Akt signaling dynamics in plasma membrane microdomains visualized by FRET-based reporters

Communicative and Integrative Biology

Volumn 2, Issue 1, 2009, Pages 32-34

  Gao, Xinxin ^a   Zhang, Jin ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Akt; Cholesterol; FRET; IGF 1; Lipid rafts; PDGF

Indexed keywords

EID: 60949097086     PISSN: None     EISSN: 19420889     Source Type: Journal    
DOI: 10.4161/cib.2.1.7420     Document Type: Article

References (17)

1. Bellacosa A, Testa JR, Staal SP, Tsichlis PN. A retroviral oncogene, akt, encoding a serinethreonine kinase containing an SH2-like region. Science 1 991; 254:274-7.
2. Jones PF, Jakubowicz T, Pitossi FJ, Maurer F, Hemmings BA. Molecular cloning and identification of a serine/threonine protein kinase of the second-messenger subfamily. Proc Natl Acad Sci USA 1991; 88:4171-5.
3. Brazil DP, Hemmings BA. Ten years of protein kinase B signalling: a hard Akt to follow. Trends Biochem Sci 2001; 26:657-64.
4. Manning BD, Cantley LC. AKT/PKB signaling: navigating downstream. Cell 2007; 129:1261-74.
5. Fayard E, Tintignac LA, Baudry A, Hemmings BA. Protein kinase B/Akt at a glance. J Cell Sci 2005; 118:5675-8.
6. Aoki M, Batista O, Bellacosa A, Tsichlis P, Vogt PK. The akt kinase: molecular determinants of oncogenicity. Proc Natl Acad Sci USA 1998; 95:14950-5.
7. Adam RM, Mukhopadhyay NK, Kim J, Di Vizio D, Cinar B, Boucher K, Solomon KR, Freeman MR. Cholesterol sensitivity of endogenous and myristoylated Akt. Cancer Res 2007; 67:6238-46.
8. Lee KY, D'Acquista F, Hayden MS, Shim JH, Ghosh S. PDKI nucleates T cell receptorinduced signaling complex tor NFkappaB activation. Science 2005; 308:114-8.
9. Jones KA, Jiang X, Yamamoto Y, Yeung RS. Tuberin is a component of lipid rafts and mediates caveolin-1 localization: role of TSC2 in post-Golgi transport. Exp Cell Res 2004; 295:512-24.
10. Gao X, Zhang J. Spatiotemporal analysis of differential Akt regulation in plasma membrane microdomains. Mol Biol Cell 2008; 19:4366-73.
11. Arcaro A, Aubert M, Espinosa del Hierro ME, Khanzada UK, Angelidou S, Tetley TD, B?ttermann AG, Frame MC, Seckl MJ. Critical role for lipid raft-associated Src kinases in activation of P13K-Akt signalling. Cell Signal 2007; 19:1081-92.
12. Lasserre R, Guo XJ, Conchonaud F, Hamon Y, Hawchar O, Bernard AM, Soudja SM, Lenne PF, Rigneault H, Olive D, Bismuth G, Nunes JA, Payrastre B, Marguet D, He HT. Raft nanodomains contribute to Akt/PKB plasma membrane recruitment and activation. Nat Chem Biol 2008; 4:538-47.
13. Ananthanarayanan B, Ni Q, Zhang J. Signal propagation from membrane messengers to nuclear effectors revealed by reporters of phosphoinosit?de dynamics and Akt activity. Proc Natl Acad Sci USA 2005; 102:15081-6.
14. Hooslimand-Rad R, Hajkova L, Klint P, Karlsson R, Vanliaesebroeck B, Claesson-Welsh L, Heldin CH. The PI3-kinase isoforms p110(alpha) and p110(beta) have differential roles in PDGF- and insulin-mediated signaling. J Cell Sci 2000; 113:207-14.
15. Katz MS. Therapy insight: Potential of statins for cancer chemoprevention and therapy. Nat Clin Pract Oncol 2005; 2:82-9.
16. Alvarez RH, Kantarjian HM, Cortes JE. Biology of platelet-derived growth factor and its involvement in disease. Mayo Clin Proc 2006; 81:1241-57.
17. Clemmons DR. Modifying IGF1 activity: an approach to treat endocrine disorders, atherosclerosis and cancer. Nat Rev Drug Discov 2007; 6:821-33-